We are live on ! Find out more
ABVX

Abivax

30 hedge funds and large institutions have $232M invested in Abivax in 2023 Q4 according to their latest regulatory filings, with 30 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

34.51% more ownership

Funds ownership: 0%34.51% (+35%)

Holders
30
Holders Change
+30
Holders Change %
% of All Funds
0.44%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
30
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
CSS
26
Cubist Systematic Strategies
Connecticut
$249K +$237K +23,300 New
SIM
27
Sandia Investment Management
Massachusetts
$214K +$204K +20,000 New
CC
28
Caxton Corporation
New Jersey
$179K +$171K +16,743 New
HighTower Advisors
29
HighTower Advisors
Illinois
$107K +$102K +10,000 New
FMP
30
Financial Management Professionals
Texas
$1K +$1.02K +100 New

ABVX Hedge Fund Activity: Q4 2023 in Review

30 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Abivax (ABVX) for Q4 2023, worth a combined $232M.

Buyers outnumbered sellers: 30 funds opened new ABVX positions and 0 closed out — a net gain of 30 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Deep Track Capital, opening a new position worth an estimated $43.8M.

  • 30 institutional investors held Abivax (ABVX) as of Q4 2023, up from 0 in Q3 2023.
  • Funds reported $232M of Abivax stock for Q4 2023.
  • 30 funds opened new Abivax positions in Q4 2023 and 0 closed out, a net change of +30 holders.
  • The largest Abivax buyer in Q4 2023 was Deep Track Capital, an estimated $43.8M added.

Based on aggregated 13F filings for Q4 2023.